Trial NCT03759288

View at ClinicalTrials.gov 
Org. Study IDs: D5271C00001
Secondary IDs: #3150-301-008 2018-004346-42

Last trial update was posted on 2023-11-21

MeSH Interventions

Adalimumab

MeSH Conditions

Crohn Disease

Other Conditions

Crohn's Disease IBD

Stopping Reasons

Strategic decision to discontinue the development of brazikumab in inflammatory bowel disease.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID